Volume 25, Number 4—April 2019
Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type-1 Transmission
|Case-patient||Age at diagnosis, y||Country of birth or ethnicity||HTLV-1 proviral load %||Route of diagnosis||HTLV-1 status of regular sexual partner||Sharing of equipment||Characteristic|
|A||34||Indian||0.8||Screening for IVF||Negative||Yes||Blood donor in UK 9 y earlier, documented HTLV negative|
|B||40||Pakistan||0.7||Cord blood donor (partner)||Positive||Yes||Hepatitis C virus co-infection now cured|
|C||47||Pakistan||0.8||Screening for IVF||Negative||Yes||Multiple previous blood donations in Pakistan|
|D||25||Pakistan||0.79||UK blood donor||No current partner||Yes||Previous blood donor in Pakistan|
|E||37||Pakistan||2.11||Cord blood donor (partner)||Positive||Yes||None|
|F||31||UK, Indian||0.14||UK blood donor||Negative||Yes||None|
|G||22||UK, Pakistani||0.4||UK blood donor||Positive||No||Received sutures in Iraq; wife seroconverted and became pregnant|
|H||33||UK, Indian||2.69||UK blood donor||Negative||Yes||None|
|I||37||Pakistan||Undetectable||UK blood donor||Negative||No||Sample/cutoff ratio >80†|
|J||38||Iraq||0.001||UK blood donor||Unknown||Yes||None|
*All case-patients were male. HTLV-1, human T-cell lymphotropic virus type 1; IVF, in vitro fertilization.
†For an enzyme immunoassay assay.
Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.